TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Modalis Therapeutics Corporation ( (JP:4883) ) is now available.
Modalis Therapeutics Corporation announced the issuance of 4,900 new shares as part of a restricted-stock-based remuneration plan for an employee of its subsidiaries. This move is intended to align employee interests with shareholders and enhance the company’s long-term value. The issuance represents a minimal dilution of 0.01% of the total shares, reflecting a strategic approach to employee compensation without significantly impacting existing shareholders.
More about Modalis Therapeutics Corporation
Modalis Therapeutics Corporation is a biotechnology company listed on the Tokyo Stock Exchange, focusing on the development of innovative therapies. The company specializes in creating treatments that aim to address unmet medical needs, leveraging its expertise in gene modulation technologies.
Average Trading Volume: 5,162,788
Technical Sentiment Signal: Hold
Current Market Cap: Yen7.23B
Find detailed analytics on 4883 stock on TipRanks’ Stock Analysis page.